1
Participants
Start Date
November 12, 2019
Primary Completion Date
January 9, 2020
Study Completion Date
January 9, 2020
Seladelpar
Capsule(s) administered orally once daily
Placebo to match Seladelpar
Capsule(s) administered orally once daily
New York University, New York
Bon Secours Liver Institute of Richmond, Richmond
Liver Institute of Virginia, Newport News
Piedmont Atlanta Hospital, Atlanta
Schiff Center for Liver Diseases/University of Miami, Miami
Henry Ford Health System, Novi
University of Colorado Denver and Hospital, Aurora
Sutter Pacific Medical Foundation - California Pacific Medical Center, San Francisco
Toronto Centre for Liver Disease-Toronto General Hospital, Toronto
ID Clinic, Mysłowice
Lead Sponsor
Gilead Sciences
INDUSTRY